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ABSTRACT
The BTAF1 transcription factor interacts with TATA-
binding protein (TBP) to form the B–TFIID complex,
which is involved in RNA polymerase II transcription.
Here, we present an extensive mapping study of TBP
residues involved in BTAF1 interaction. This shows
that residues in the concave, DNA-binding surface of
TBP are important for BTAF1 binding. In addition,
BTAF1 interacts with residues in helix 2 on the convex
side of TBP as assayed in protein–protein and in
DNA-binding assays. BTAF1 drastically changes the
TATA-box binding specificity of TBP, as it is able to
recruit DNA-binding defective TBP mutants to both
TATA-containing and TATA-less DNA. Interestingly,
other helix 2 interacting factors, such as TFIIA and
NC2, can also stabilize mutant TBP binding to DNA.
In contrast, TFIIB which interacts with a distinct
surface of TBP does not display this activity. Since
many proteins contact helix 2 of TBP, this provides a
molecular basis for mutually exclusive TBP interac-
tions and stresses the importance of this structural
element for eukaryotic transcription.
INTRODUCTION
TATA-binding protein (TBP) is required for transcription by
all three eukaryotic RNA polymerases (1). Each type of RNA
polymerase employs different TBP-containing multiprotein
complexes. In the case of human RNA polymerase I, TBP
is complexed with three TBP-associated factors (TAFs),
TAFI48, TAFI63 and TAFI110 into the SL1 complex. RNA
polymerase III employs the TFIIIB complex, which consists of
TBP, Brf1 and Bdp1 proteins (2). RNA polymerase II (pol II)
is able to use TBP embedded within two factors: TFIID and
B–TFIID (2–5). TFIID is a 700 kDa complex consisting of
TBP and 13 highly conserved TAFs (6). B–TFIID is composed
of TBP and one protein, BTAF1 (7).
The BTAF1 protein belongs to the family of SNF2-like
ATPases (8,9). The N-terminal third of the protein
(600 amino acids) was shown to contain several discrete
regions, which are able to interact independently with TBP
(10–14). These regions coincide with predicted pairs of
HEAT/ARM repeats (5,15). BTAF1 is highly conserved
throughout evolution and its Saccharomyces cerevisiae ortho-
log, Mot1p, is also found in a stable complex with TBP (16).
The ATPase domain of BTAF1/Mot1p is located within the C-
terminal third. Limited mutational analysis of yeast and human
TBP showed that both its concave DNA-binding and convex
solvent-exposed surfaces are used in BTAF1/Mot1p interac-
tion (10–14). BTAF1 associates stably with a significant frac-
tion of TBP in human cell lysates (17). The resulting B–TFIID
complex is able to bind promoter DNA and support basal
transcription in vitro (17,18). The Mot1p–TBP complex dis-
plays high affinity binding to a broad range of DNA sequences
(19). It is not clear what the exact role of BTAF1 in the pre-
initiation complex (PIC) assembly is. BTAF1 could be accom-
modated in the active PIC together with basal transcription
factors (BTFs) and pol II. Alternatively, BTAF1 could deliver
TBP to promoter DNA and subsequently dissociate from TBP
as the result of competition with BTFs or upon the action of
factors such as TFIIA or NC2. Interestingly, the NC2a but not
*To whom correspondence should be addressed. Tel: +31 30 253 8981; Fax: + 31 30 253 9035; Email: h.t.m.timmers@med.uu.nl
Present addresses:
Marcin P. Klejman, Department of Molecular Biology, International Institute of Molecular and Cell Biology, ul. Ks. Trojdena 4, 02-109 Warsaw, Poland
Xuemei Zhao, Proteomics, Department of Molecular Profiling, Merck Research Laboratories, Rahway, NJ 07065, USA
Winship Herr, Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland
 The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
5426–5436 Nucleic Acids Research, 2005, Vol. 33, No. 17
doi:10.1093/nar/gki850
NC2b subunit of the NC2 complex interacts with BTAF1 and
stimulates BTAF1–TBP interaction (20). In vivo experiments
in yeast demonstrate that Mot1p is present at many active
promoters and is required for TBP recruitment to at least
some of them (21–23). Moreover, Mot1p was shown recently
to co-occupy active promoters with TFIIB and pol II under
stress conditions, which led to the proposal that stress activates
Mot1p–TBP complexes (24).
BTAF1 and Mot1p are also able to dissociate TBP from
DNA in vitro, which requires their ATPase function (9,14,18).
Consequently, BTAF1 and Mot1p were proposed to act as
repressors of transcription. In agreement with this, several
fragments of the N-terminal part of BTAF1/Mot1p can contact
the concave DNA-binding surface of TBP and inhibit its bind-
ing to DNA and consequently pol II transcription (10,11). A
model was proposed in which BTAF1/Mot1p dissociates TBP
from DNA by inserting its N-terminal region as a ‘wedge’
between TBP and DNA. Alternatively, BTAF1/Mot1p could
alter the conformation of TBP–DNA complexes. Several
observations indicate that BTAF1/Mot1p does not act as clas-
sical DNA helicase or a DNA tracking enzyme (25–27).
To obtain insight into the function of BTAF1 in TBP activ-
ity we have analysed BTAF1–TBP interaction both off and on
the DNA. Here, we report comprehensive mapping of the TBP
surfaces contacted by BTAF1. The convex surface in the
region of helix 2 and the concave surface of TBP are both
involved in BTAF1 binding. Strikingly, DNA binding of TBP
with mutations in the concave, but not in the convex surface
can be rescued by BTAF1. Moreover, BTAF1 drastically
changes the TATA-box specificity of TBP, as DNA-binding
mutants of TBP can be rescued for the interaction with TATA-
box or TATA-less DNA by addition of BTAF1. At the same
time, we show that BTAF1 does not require contacts with the
DNA-binding surface of TBP to disrupt TBP–DNA com-
plexes. We compare the ability of BTAF1 to stabilize
TBP–DNA complexes with other TBP-interacting proteins,
TFIIA, TFIIB and NC2. Our data indicate that BTAF1 inter-
acts with surfaces of TBP overlapping with those of TAF1,
TFIIA, NC2, Brf1 and TAFI48 and that BTAF1 shares the
ability to stabilize TBP–DNA complexes with several other
regulators of TBP function.
MATERIALS AND METHODS
Proteins
TBP proteins were expressed and purified as described previ-
ously (28). Briefly, plasmids carrying GST-TBP mutant
cDNAs were constructed by site-directed mutagenesis of
the pET11c-GST-TBP plasmid. Protein expression was
induced by addition of 0.4 mM isopropyl thiogalactopyranos-
ide to BL21(DE3) bacteria carrying appropriate GST-TBP
plasmids. After lysis, proteins were bound to glutathione-
agarose beads (Sigma) and the resin was washed extensively.
The last wash consisted of thrombin cleavage buffer (50 mM
Tris–HCl, pH 8.0, 150 mM NaCl, 2 mM CaCl2 and 1 mM
EDTA). Subsequently, thrombin was added to release TBP
from the GST moiety. Supernatants containing human TBP
proteins were collected and protein inhibitor cocktail
(Pefabloc, Roche) and DTT were added in final concentrations
of 200 mg/ml and 10 mM, respectively. Samples were dialyzed
against D100 buffer [20% glycerol, 20 mM HEPES–KOH,
pH 7.9, 100 mM KCl, 0.2 mM EDTA, 2 mM DTT, 1 mM
phenylmethylsulfonyl fluoride (PMSF)] and stored at 80C.
TBP protein concentrations were normalized based on
Coomassie staining and immunoblotting with TBP antibodies.
Recombinant human TFIIB was purified to near homogen-
eity as described previously (29). Recombinant human
NC2(hisa/b) complex was purified as described previously
(20). Recombinant, unprocessed TFIIA protein was a kind
gift of H. Stunnenberg and H. Zhou. BTAF1 protein used
for co-immunoprecipitation experiments (Figure 1A) or for
electrophoretic mobility shift assay (EMSA) was supplied
as a lysate of RK13 cells infected with BTAF1 and T7
RNA polymerase-encoding vaccinia viruses to overexpress
full-length human recombinant BTAF1 (20).
TBP–BTAF1 solution binding assay
Equal amounts of the indicated TBP proteins (50 ng) were
incubated with 5 ml of BTAF1-containing RK13 cells lysate in
500 ml of binding buffer (50 mM Tris–HCl, pH 8.0, 300 mM
KCl, 1 mM EDTA, 1 mM DTT, 0.01% Triton X-100, 0.5 mM
PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 1 mg/ml
pepstatin) for 2 h on ice. Subsequently, 100 ml of 10% protein
A agarose beads equilibrated in binding buffer and 1.6 mg of
purified, monoclonal 1F8 anti-TBP antibodies (18) were added
to the reactions. Reactions were incubated overnight with
tumbling and the beads were washed three times with binding
buffer. Immunoprecipitated TBP and BTAF1 were resolved
using SDS–PAGE and detected by immunoblotting with
specific antibodies.
Electrophoretic mobility shift assay
EMSAs were performed as described previously with small
modifications (18,20,28). Radiolabelled probe consisting of
adenovirus major-late promoter fragment 53 to 12 was
used. The probe contained wild-type TATA-box, except in
Figure 3 where the TATAAAAG sequence was replaced by
CGCAAACG as indicated. Indicated proteins were incubated
without the probe in 10 ml reaction volumes for 5 min at 4C.
Reaction buffer contained 20 mM HEPES–KOH, pH 7.9,
1 mM Tris–HCl, pH 8.0, 60 mM KCl, 5 mM MgCl2,
500 ng/ml BSA, 10% glycerol, 0.25 mM EDTA, 7 mM
DTT and 0.1% Tween-20. Subsequently, 0.3 ng of radiola-
belled probe and 2 ng of poly(dG-dC):poly(dG-dC) was added
and the reactions were incubated for 30 min at 30C. In
Figure 4 ATP (40 mM) was supplied 5 min before gel loading.
Electrophoresis was performed as described previously (28).
Intensities of specific bands were quantified using a Storm 820
PhosphorImager (Amersham) and Image QuaNT software.
The ability of BTAF1, TFIIA, NC2 and TFIIB to form ternary
complexes with TBP mutant proteins and DNA (Table 2) was
calculated based of the titration experiments with various
amounts of transcription factors, wild-type TBP and DNA.
RESULTS
TBP mutants defective in BTAF1 interaction in vitro
Eighty-five TBP mutant proteins containing mutations in 57
surface exposed residues were tested for the interaction with
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the BTAF1 transcription factor. Mutants were designed to
encompass various surfaces of TBP, including convex and
concave sides (Figure 1B and Table 1). TBP mutants were
mixed with saturating amounts of BTAF1 from cell lysates
highly enriched in full-length BTAF1. BTAF1–TBP com-
plexes were recovered with 1F8 TBP monoclonal antibody
directed against residues 56–97 within the N-terminus of
human TBP. Several mutants showed a complete loss of inter-
action with BTAF1 (Figure 1A and Table 1, column 2). Ana-
lysis of the mutants revealed that two major regions of TBP are
important for interaction with BTAF1. The first region mapped
to the upper side of the first TBP repeat in the area of helix 2
(Figure 1B, top view). Exposed charged residues R235, K236,
R239 and K243 in helix 2 (H2) were particularly sensitive to
mutagenesis, both to alanine and to opposite charge (Table 1).
Additionally, some mutants (in residues L244, K249, F250
and F253) within the loop between H2 and strand 10 (S10)
and in S10 were also affected (Figure 1B, top view). The
surface seemed to extend towards the side of TBP, since muta-
tion of residues within the helix 1 and the loop linking H1
Figure 1. Interaction of BTAF1 with mutant TBP proteins. (A) Representative results of BTAF1–TBP interaction assay in solution. Binding reactions were
performed as described in Materials and Methods. Lane 5 contained wild-type TBP (50 ng), lanes 6–19 contained indicated mutant TBP proteins (50 ng) and no TBP
was added to lane 20. Lanes 5–20 contained 5 ml of BTAF1-enriched lysate. BTAF1 and TBP proteins were co-immunoprecipitated using TBP antibody. Indicated
amounts of BTAF1-containing lysate were loaded as the input control (lanes 1–4). Proteins were visualized using specific antibodies. (B) Human TBP model (30)
showing results of BTAF1–TBP interaction. Top left—view from upstream DNA; top right—view from downstream DNA (start site); bottom left—view on the top
(convex) TBP surface; and bottom right—view on the DNA-binding (concave) TBP surface. Residues affected in BTAF1–TBP interaction by mutations in TBP are
indicated (Table 1, column 2): red, <25% of the wild-type TBP interaction; yellow, 25–50% of the wild-type interaction; and blue, 50–100% of the wild-type
interaction. Double mutations were marked in blue only if they retained 50–100% of the wild-type interaction.
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with the stirrup (R186, N189) also affected the interaction
(Figure 1B, upstream view). At the same time, mutants in
the vicinity of helix 1 (K177 and K181) facing the transcrip-
tion start site were not affected (Figure 1B, downstream view).
This suggested that BTAF1 does not engage the whole side of
the first repeat of TBP. Interestingly, the surface centred at
helix 2 was encircled by residues, where mutations had limited
or no effect on the interaction with BTAF1. This included
residue E228 towards the centre of the upper surface of
TBP (Figure 1B, top view). From the downstream-facing
side the interacting surface was enclosed by non-affected
residues L251 and D252 (Figure 1B, downstream view).
From the upstream-facing side residues E206 and R208
were not affected by mutations (Figure 1B, upstream view).
Thus, the mutagenesis delineated the specific BTAF1-binding
surface on top and side of the first TBP repeat.
Table 1. Formation of the BTAF1–TBP, TBP–DNA and BTAF1–TBP–DNA
complexes
TBP mutanta Complex formation
BTAF1–
TBPb
TBP–
DNAc
BTAF1–
TBP–DNAd
BTAF1–TBP–
DNAe/
TBP–DNA
wild-type + + + 1.0
I161A   ± /
V162A   + /
K177A + + + 1.7
H1 K181E + ± + 4.1
H1 L185A ±  + 6.0
H1 L185K + ± + 3.4
H1 R186A   + 4.7
H1 R186E  + ± 0.3
R188A ± + ± 0.2
R188E ± +  0.0
R188E/
T210K
   /
R188E/
L287A
 +  0.1
N189A  ± ± 1.1
N189E  ±  0.4
N189K   + /
S2 E191K ± * + /
stirrup K195A + + + 1.3
stirrup R196A + * + /
S3 R203A  *  /
S3 R203E  * + /
R205A ± + + 0.8
R205E ±   0.9
E206K + + + 0.6
R208E + * + /
S4 T210A + * + /
S4 T210K + * + /
S4 L212A  * + /
F214A  * ± /
S5 K218A  * + 14.7
S5 K218E  * ± /
H2 E228A + + + 1.7
H2 E228K + + + 0.8
H2 R231A ± n.d. n.d. n.d.
H2 R231E + + + 0.3
H2 L232A ± + + 1.6
H2 L232K + + ± 0.5
H2 R235A  + ± 0.3
H2 R235E  n.d. n.d. n.d.
H2 K236A  + ± 0.3
H2 K236E  + + 0.2
H2 R239A  + ± 0.2
H2 R239E  + + 0.1
H2 V240A + ± + 3.1
H2 V240L ± ± + 2.6
H2 V240D  ± ± 0.8
H2 V240K ±  + /
H2 Q242A + + + 1.3
H2 Q242K + + + 1.4
H2 K243A  +  0.1
H2 K243E  + ± 0.1
L244K    /
K249A   ± /
F250A + + + 0.7
F250K    /
S10 L251A + + + 0.8
S10 D252A + ± + 2.4
S10 F253A    /
S10 F253K    /
S10 K254A ±  + /
K265A ±  + 11.0
H10 R269A/
E271A
+ + + 0.5
Table 1. Continued
TBP mutanta Complex formation
BTAF1–
TBPb
TBP–
DNAc
BTAF1–
TBP–DNAd
BTAF1–TBP–
DNAe
TBP–DNA
H10 L275A + ± + 2.5
H10 L275K + + + 0.7
Q279A + + + 1.5
stirrup’ E284R ± + + 0.3
stirrup’ E284N/
E286A
± + + 1.5
stirrup’ E286R ± + + 0.4
stirrup’ L287A ± * + /
stirrup’ F288A  n.d. n.d. n.d.
stirrup’ F288K  * ± /
S30 R294A  * + /
I296A + + + 0.7
K297A   ± /
K297A/R299A   ± /
R299A + * + /
F305A  * ± /
F305K  * ± /
S50 K309A  * + /
S50 K309E  * ± /
H20 R318A ±  + /
H20 E320A ±  ± /
H20 E323A/E326A +  + 4.6
H20 N327A + ± + 3.0
H20 K333A + ± + 3.2
R336A + ± + 3.1
aTBP mutants deficient in TBP–BTAF1 complex formation in co-
immunoprecipitation experiment are highlighted in bold. Structural elements
of TBP are indicated.
bAnalysed in co-immunoprecipitation experiments; plus,>50% of the wild-type
TBP–BTAF1 complex; plus-minus, 25–50% of the wild-type TBP–BTAF1
complex; minus, <25% of the wild-type TBP–BTAF1 complex. Results
were averaged from two to four independent measurements.
cAnalysed in EMSA; plus, >50% of the wild-type TBP–DNA complex; plus-
minus, 25–50% of the wild-type TBP–DNA complex; minus,<25% of the wild-
type TBP–DNA complex. Asterisk, TBP residues interacting with DNA in the
crystal structure (30).
dAnalysed in EMSA; plus,>50% of the wild-type BTAF1–TBP–DNA complex;
plus-minus, 25–50% of the wild-type BTAF1–TBP–DNA complex; minus,
<25% of the wild-type BTAF1–TBP–DNA complex.
eRatio calculated from intensities of TBP–DNA and BTAF1–TBP–DNA com-
plexes measured in the same experiment. Ratio was set to 1.0 for wild-type TBP.
Slash, low abundance of the TBP–DNA complex prevents calculation of the
ratio.
n.d., not determined.
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The second TBP region, which was affected in BTAF1
binding by mutations was the DNA-binding, concave surface.
The majority of residues shown to contact DNA in the crystal
structure of human TBP were also sensitive to mutagenesis
(Table 1) (30). These included amino acids R203, L212, F214
and K218 from the first TBP repeat and residues F288, R294,
F305 and K309 from the second TBP repeat (Figure 1B,
bottom view). Our mutagenesis identified only four
DNA-interacting residues, which had no effect on BTAF1
interaction upon mutation. These included R196 in the first
stirrup, R208 and T210 in S4 and R299 in S40 (Figure 1B,
bottom view).
The second interacting surface was not restricted to the
DNA-binding region of TBP. Instead, it seemed to span
upwards on the upstream-facing side of the second TBP repeat,
as residues I161 and V162 were also sensitive to mutagenesis
(Figure 1B, upstream view). Collectively, the second TBP
region involved in BTAF1 interaction includes its concave
surface and small parts on one side of the second repeat.
BTAF1 affects TBP–DNA interaction
To corroborate the results presented above, we tested the TBP
mutant proteins for their ability to form ternary complexes
with BTAF1 and TATA-box DNA. Results of these experi-
ments are summarized in Table 1. As described previously,
wild-type TBP was able to form a specific complex with the
TATA-box (Figure 2, lanes 1 and 37) (18,20). Several
mutants, such as V240A and Q242A, also formed DNA com-
plexes with similar mobility (Figure 2, lanes 29 and 41; data
not shown). A specific set of mutants (e.g. R186E and R188E)
migrated slightly faster when complexed with DNA (Figure 2,
compare lanes 1, 13 and 17; data not shown). Those mutants
were described previously to bend DNA under similar condi-
tions without formation of an intermediate, non-bend complex
(28). The difference in mobility of TBP–DNA complexes with
the previous study is probably owing to the length of DNA
used. Several TBP mutant proteins were unable to form a
TBP–DNA complex (Figure 2 and Table 1). These fell within
two groups. The first consisted of mutants in residues involved
directly in DNA binding as determined by crystallography
(marked by an asterisk in Table 1) (30). The second group
consisted of residues, which do not contact DNA in the
crystallographic structure (30). The behaviour of these
mutants may indicate changes in conformation or plasticity
of TBP.
Addition of BTAF1 to the wild-type TBP resulted in the
formation of the slower migrating BTAF1–TBP–DNA
Figure 2. Analysis of the BTAF1–TBP–DNA complex formation by selected TBP mutants. EMSA reactions were performed as described in Materials and Methods
with equal amounts of indicated TBP proteins (50 ng) and with the increasing amounts of BTAF1-containing lysate (0.022, 0.067 and 0.2 ml) as indicated. Lanes 33–
36 and 69–72 did not contain TBP. Positions of TBP–DNA and BTAF1–TBP–DNA complexes are shown. Asterisk denotes a complex different from BTAF1–TBP–
DNA originating from the BTAF1-enriched lysate.
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complex, consistent with the results published previously
(Figure 2, lanes 1 to 4 and 37 to 40) (9,18,20). The specificity
of this complex was confirmed by supershift with BTAF1
antibodies (data not shown) (20) and by sensitivity to ATP
(Figure 4). Most strikingly, the pattern of BTAF1–TBP–DNA
ternary complex formation did not follow the results obtained
in direct BTAF1–TBP binding assay (Figure 2 and Table 1,
compare columns 2 and 4). BTAF1 was able to induce DNA
binding for the majority of the DNA-binding surface TBP
mutants (Table 1, compare columns 3 and 4). This included
also mutants defective for BTAF1 binding in solution. Only
few mutants in the DNA contacting residues failed to form the
ternary complex. These included a radical mutation in F288
(F288K), which has been shown to intercalate between
DNA bases in the crystal structure of TBP and K309E and
R203A, which contact the phosphate backbone of DNA. This
indicates that BTAF1 drastically alters the DNA binding
properties of TBP. In fact, BTAF1 interaction circumvents
the requirement of TBP to tightly interact with DNA. Addi-
tionally, this finding is consistent with the expectation that
BTAF1 does not engage the concave surface of TBP when
forming the complex with DNA.
The opposite results were obtained using TBP mutants in
the convex surface. In this case the efficiency of BTAF1–
TBP–DNA complex formation in comparison with TBP–
DNA could be determined since most of the TBP mutants
in this region retained DNA-binding activity. All helix
2 mutants affected in BTAF1–TBP complex formation in
solution were also severely compromised in BTAF1–TBP–
DNA complex assembly when compared with wild-type
TBP (Table 1, column 5). In contrast, residues in helix 2,
which were able to form the BTAF1–TBP complex, such
as E228 and Q242, were also competent in the formation
of the BTAF1–TBP–DNA complex with a similar
efficiency as wild-type TBP. These results suggest that
BTAF1 engages exclusively the upper surface of TBP when
it is bound to DNA.
BTAF1 alleviates TATA-box requirement of TBP
Our findings indicated that BTAF1 can stabilize TATA-
binding of TBP mutants compromised in their DNA binding
surface. It has been shown that Mot1p binding to TBP alters
its specificity of DNA recognition (19). To extend this
observation to BTAF1 we tested whether TATA-box
sequences are required for BTAF1-TBP-DNA complex forma-
tion. We used a DNA probe carrying AdML promoter with
TATAAAAG sequences mutated to CGCAAACG and ana-
lysed DNA binding of a set of TBP mutants. As expected,
wild-type TBP was completely deficient in binding to the non-
TATA DNA (Figure 3, compare lanes 1 and 36). However,
addition of BTAF1 fully rescued its interaction with DNA
(Figure 3, compare lanes 4 and 37). Similar to results with
the TATA probe (Figure 2), binding of many TBP mutants to
the non-TATA DNA could be rescued by BTAF1. The relative
efficiencies of rescue did not differ significantly between the
two probes. For example, R186E and F288K are less effi-
ciently rescued when compared with wild-type TBP both
on TATA and non-TATA probe. These results strengthen
the observation that BTAF1 dramatically changes DNA inter-
action properties of TBP.
BTAF1 does not require efficient interaction
with the concave surface of TBP for its
dissociation from DNA
Based on observations that BTAF1 can directly contact the
concave surface of TBP (Table 1) (10,11), we proposed that
BTAF1 may dissociate TBP from DNA by inserting its
N-terminal regions between TBP and DNA. This ATP-
dependent step could require BTAF1 contacting the concave
surface of TBP to disrupt its interaction with DNA. We have
tested this hypothesis by selecting TBP mutants, which were
defective in the formation of TBP–DNA and BTAF1–TBP,
but were able to form the BTAF1–TBP–DNA complex on
TATA-box containing DNA (Figure 4, lanes 1–18)
Figure 3. BTAF1–TBP–DNA complex formation on TATA-less DNA. EMSA reactions were performed as described in Materials and Methods. Lanes 1–35
contained TATA-less DNA probe (CGCAAACG), whereas lanes 36 and 37 contained TATA-box DNA probe (TATAAAAG). Various TBP mutant proteins (50 ng)
were added as indicated. Lanes 2–5 received 0.017, 0.033, 0.067 and 0.2 ml of BTAF1 lysate. Odd lanes 7–37 received 0.067 ml of BTAF1 lysate. Asterisk denotes a
complex different from BTAF1–TBP–DNA originating from the BTAF1-enriched lysate.
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(Table 1). Upon addition of ATP these BTAF1–TBP–DNA
complexes were disrupted with similar efficiency as the
wild-type complex (Figure 4, lanes 19–27). Similar results
were obtained using TATA-less DNA probe (data not
shown). Thus, BTAF1 does not require binding to the concave
surface residues in order to dissociate TBP from DNA.
TBP mutants specifically defective in BTAF1,
TFIIA and NC2 interaction
Several TBP-interacting factors, including TFIIA and NC2,
were implicated in binding to the first repeat of TBP (31–35).
Therefore, we used DNA-binding assay to identify TBP
mutants, which are specifically defective in the interaction
with BTAF1, TFIIA, NC2 or TFIIB. Wild-type TBP was
able to form complexes with BTAF1, TFIIA, NC2 and
TFIIB as expected (Figure 5, lanes 1–5) (20,28). Several
TBP proteins with mutations in the first repeat exhibited
lack of binding to one of the factors tested (Table 2 and
data not shown). For example, R188E was specifically affected
in the formation of complexes with BTAF1 or NC2, but not
with TFIIA and TFIIB (Figure 2, compare lanes 1–5 and
6–10). K243E mutant was affected in the formation of com-
plexes with BTAF1 and TFIIA, but not with NC2 or TFIIB
(Figure 5, compare lanes 1–5 and 11–15). The TBP(K243E)–
TFIIA–TATA complex (lane 13) seems to be migrating
slightly slower, but we do not consider this significant as it
was not observed reproducibly (data not shown). Thus, we
identified TBP mutants, which are selectively defective for
BTAF1/TFIIA or BTAF1/NC2 interaction.
Next, we analysed whether similarly to BTAF1 other factors
could rescue the activity of DNA-binding defective TBP
mutants. This was also motivated by findings of others that
binding of some yeast TBP mutants to DNA can be rescued
by TFIIA or NC2 (32,35,36). We analysed our set of TBP
mutants and Table 2 indicates that both TFIIA and NC2 could
rescue a specific set of mutants. In contrast, TFIIB was
markedly less effective in stabilizing DNA binding of TBP
mutants (Table 2, column 7). Together, these data suggest that
BTAF1, TFIIA and NC2 may similarly influence TBP binding
to DNA, whereas TFIIB differs from the other factors tested.
Only limited set of TBP mutants could be differentially
recruited to DNA by various factors. For example, T210K
TBP mutant could only be rescued by BTAF1 and NC2,
but not by TFIIA and TFIIB (Figure 5, compare lanes
16–20 and 21–25).
Figure 4. BTAF1 disrupts mutant TBP–DNA complexes. EMSA was performed as described in Materials and Methods using a TATA-box DNA probe. Equal
amount (50 ng) of wild-type TBP or indicated mutant TBP proteins were assayed alone (lanes 1–9), with 0.067ml of BTAF1 lysate (lanes 10–27) and in the presence of
40 mM ATP (lanes 19–27).
Figure 5. Analysis of the ability of selected TBP mutants to form TBP–DNA
complex with BTAF1, TFIIA, TFIIB and NC2. EMSA reactions were per-
formed as described in Materials and Methods with 50 ng of indicated TBP
proteins. Reactions contained 0.1 ml of BTAF1 lysate, 0.01 ml of recombinant,
unprocessed TFIIA (identical result was obtained using endogenous, HeLa
cells-derived TFIIA), 3 ng of recombinant NC2 (hisa/b) (20) and 120 ng of
recombinant TFIIB (10) as indicated. Asterisks on the left side of the lanes show
specific complexes formed with indicated factors. Differences in mobility of
specific quaternary complexes are probably owing to the faster migration of the
corresponding mutant TBP–DNA complexes.
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DISCUSSION
BTAF1 interacts with an extended surface of TBP
We have presented an extensive analysis of residues of TBP
involved in binding to the BTAF1 transcription factor. Two
surfaces of TBP are involved in BTAF1 interaction: upper
surface around helix 2 and parts of helix 1 and the concave,
DNA-binding surface. Several residues within those TBP
regions have been implicated previously in BTAF1 or
Mot1p binding. Residue K243 of human TBP was shown to
be essential for BTAF1 binding in vivo (10). Similarly, single
mutations K127L, K138L and K145L (K225, K236 and K243
in human TBP numbering) within the region of helix 2 of yeast
TBP were shown to abolish Mot1p binding either in solution or
in EMSA (11,13). Also, double mutations K133L/K138L,
K133L/K145L and K138T/Y139A displayed similar lack of
Mot1p binding (12,14). Likewise, the triple mutation in the
concave surface of human TBP (I292F/V301T/L303V) resul-
ted in lack of BTAF1 binding in vivo and in the yeast two-
hybrid (10). Mutations V71E and V161E (human V169 and
V259) in the concave surface of yeast TBP also prevented
Mot1p interaction (11). Our analysis extends these previous
results and constitutes the first extensive mapping study of the
BTAF1–TBP interaction surface. Given the similarity between
human BTAF1 and yeast Mot1p we expect that similar resi-
dues of yeast TBP are involved in Mot1p interaction.
Common TBP interaction surface for all TAFs
The upper TBP surface engaged by BTAF1 shows a striking
overlap with the surfaces proposed to be contacted by a pol II
TAF (TAF1), a pol III TAF (Brf1), a pol I TAF (TAFI48),
TFIIA and NC2 (31–35,37–40). This result bears important
implications for the structural basis of the assembly of various
TBP-containing complexes. It was proposed that TBP is able
to form functionally unique complexes based on its mutually
exclusive interactions with TAFs. The excluding interactions,
which were experimentally confirmed include TAF1, TAF2
and TAFI48 (40,41), TFIIA and NC2 (42,43), BTAF1 and
NC2 (20), Mot1p and TFIIA (14). Our results provide the
structural basis for the two latter results. Also, we speculate
that the overlap in TBP binding surfaces of various TAFs is
responsible for the formation of the B–TFIID complex, which
besides BTAF1 lacks other TAFs (7).
The comparison of TBP-interacting fragments of BTAF1
with TAF1, Brf1 and TAFI48 indicates that BTAF1 may bind
TBP in a unique way. BTAF1 contacts both convex and
concave TBP surfaces with 600 residues region (10,18).
Similarly, two regions within first 800 residues of yeast
Mot1p were implicated in TBP interaction (11,44). These
domains are probable to be structured into several HEAT/
ARM repeats, which consist of two-three helices tightly
bound by hydrophobic interactions (15). In contrast, TAF1,
Brf1 and TAFI48 interact with TBP by means of much shorter
domains, 70–230 amino acids in length (37,38,40,45) and
these bear no resemblance to HEAT/ARM repeats. Interest-
ingly, TBP-interacting domains of TAF1 and Brf1 seem to
undergo a significant reorganization of their secondary struc-
ture upon TBP binding (38,45). BTAF1 must also change its
conformation in order to free the concave TBP surface for the
DNA binding. At present, it is not known whether HEAT/
ARM repeats of BTAF1 also undergo extensive secondary
structure change or whether any changes are restricted to
adjustments in the relative HEAT/ARM repeats position.
Regulation of TBP–DNA interactions
through helix 2 region
We show that the DNA binding properties of TBP are influ-
enced significantly by BTAF1, since the BTAF1–TBP–DNA
complex can be formed on TATA-less DNA (Figure 3). The
change in TATA-box specificity of B–TFIID is consistent with
Table 2. Analysis of TBP–DNA complexes with various transcription factors
TBP mutant Complex formationa
TBP–DNA BTAF1–TBP–DNA BTAF1–TBP–mDNAb TFIIA–TBP–DNA NC2–TBP–DNA TFIIB–TBP–DNA
wild-type + + + + + +
V162A  + + + ± 
L185A  +  ±  ±
R186E + ±  + ± 
R188E +   +  +
N189E ±  n.d.  ± +
E191K  + + + + 
K195A + + n.d. + + +
R208E  + n.d. ± + 
T210K  + +  + 
V240A ± + + + ± ±
Q242A + + + + ± ±
K243E + ± n.d.  + +
K249A  ±    
K254A  + + + + 
K265A  + + + + ±
F288K  ±    
R299A  + + + + ±
R318A  + + + + 
aAnalysed in EMSA as described in Materials and Methods; plus, >50% of the wild-type TBP–DNA complex with indicated factor; plus-minus, 25–50% of the wild-
type TBP–DNA complex with indicated factor; minus, <25% of the wild-type TBP–DNA complex with indicated factor.
bmDNA—EMSA probe bearing the mutated TATA-box (CGCAAACG).
n.d., not determined.
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properties previously ascribed to the yeast Mot1p–TBP
complex (19). Interestingly, the affinity of Mot1p–TBP for
a TATA sequences is not higher as compared with free
TBP. This suggests that the binding to mutated TATA is
not owing to the general increase in affinity of Mot1p–TBP
or B–TFIID for DNA, but is rather a result of the changed
mode of TBP–DNA interaction. Moreover, human TBP pro-
teins with mutations in the DNA-interacting residues can be
rescued for ternary complex formation with BTAF1 (Figure 3).
Interestingly, our analysis indicates that TFIIA and NC2 are
also able to stabilize TBP–DNA complexes of TBP mutants
otherwise defective in DNA binding (Figure 5 and Table 2).
This property of TFIIA and NC2 has been demonstrated
before for certain DNA-binding defective yeast TBP
mutants (K110L, K120L, K127L, K201L and K218L in the
case of TFIIA, and K110L, L114K, K120L, L189K and
K201L in the case of NC2) (32,35,36). In contrast, TFIIB
does not possess such activity towards most of the mutants
tested (Table 2) (36). In this respect our study represents the
first comprehensive comparison of the DNA complexes
formed by a uniform set of TBP mutants with four different
TBP-interacting proteins.
Intriguingly, BTAF1, TFIIA and NC2 utilize the TBP
region, which overlaps with the inhibitory DNA-binding
(IDB) surface of TBP (28). Mutations in the IDB residues
(e.g. R188, K236, R239 and K243) lead to the facilitated
isomerization from a TBP–DNA complex containing unbent
to bent DNA and to the stabilization of TBP binding to
DNA. Moreover, the non-conserved N-terminal part of
yeast TBP was proposed to interact with helix 2 of the
DNA-bound TBP (46). Deletions of the N-terminus of
human TBP result in enhanced DNA binding and bending
(28,47). Moreover, DNA binding of some yeast TBP
mutants can be rescued by removal of the N-terminus (32).
In addition, the combination of deletion of the non-conserved
N-terminal TBP part and mutations in the IDB region of
TBP results in yeast lethality, suggesting that these two
regions of TBP cooperate (48). Our results suggest that factors
binding to the region of helix 2 could influence TBP-DNA
interaction by a common mechanism involving actions on
the IDB surface or displacement of the N-terminal part of
TBP from the TBP core. Notably, TFIIB was previously
shown to cooperate with the IDB surface and enhance
DNA binding and bending by TBP (28,35,49). In the experi-
mental conditions described above we do not generally detect
TFIIB-mediated enhancement of TBP mutants binding to
DNA (Figure 5). Therefore, ability of BTAF1, TFIIA and
NC2 to recruit DNA-defective TBP mutants to DNA is an
activity distinct from the one described for TFIIB. This
may reflect the fact that TFIIB uses a distinct TBP surface
for interaction. Since stable TBP–DNA contacts are not
required for TBP recruitment to DNA in our EMSA
(Figures 2 and 3), we favour the hypothesis that BTAF1,
TFIIA and NC2 influence an early step in the TBP–DNA
complex formation.
Mechanism of BTAF1-mediated TBP
removal from DNA
Several mechanisms for ATP-dependent TBP dissociation
from DNA by BTAF1 have been postulated
(5,10,11,19,26). The observation that BTAF1 interacts with
the DNA-binding surface of TBP in solution is central to one
of them (10,11). BTAF1 has been proposed to insert its
N-terminal domain between TBP and DNA, thereby dis-
lodging TBP from DNA. Since the DNA upstream of the
TBP-binding site does not seem to be absolutely required
for this action (19,26), we have focused on the role of the
concave TBP surface. Using a panel of mutants, we show
that BTAF1 does not require stable interaction with the
DNA-binding surface of TBP in order to dissociate TBP
from DNA (Figure 4). Previous observations in yeast utilized
Mot1p and two different DNA-binding deficient mutants of
yeast TBP (K127L and spm3). However, mutant K127L is
situated on the edge of helix 2, contacts DNA backbone via
a water-molecule and is solvent-exposed (11,30). Another
study used the relaxed specificity yTBP spm3 mutant
(I194F/V203T/L205V) within the concave surface (25). A
complication in the analysis of this mutant is that it is
still able to interact with TATA-box DNA. Thus, our data
represent the first extensive study of multiple TBP molecules
with mutations buried within its DNA-binding surface. Our
data suggest that a mere competition between BTAF1 and
DNA is not sufficient to explain BTAF1-mediated TBP–
DNA dissociation and that a more complicated mechanism
is at work. It is possible that BTAF1/Mot1p interaction
with DNA is involved in TBP removal (26). BTAF1 could
compete with TBP for the minor groove of TBP-bound
DNA. Alternatively, it could contact the major groove of
DNA opposite of TBP-bound DNA and change its structure.
However, the fact that Mot1p is able to disrupt a TBP–DNA
complex on constrained minicircle DNA seems to disfavour
the latter hypothesis (26). BTAF1 could also dissociate TBP
from DNA by changing the conformation of TBP (19),
without the need for direct interactions with the concave
TBP surface. Interestingly, biophysical data suggest that
Mot1p and TBP do not dissociate from DNA as a complex,
but rather as separate proteins (19). These observations
should motivate development of (biophysical) methods to
investigate conformational alterations in the TBP molecule
itself.
TBP mutant proteins as tools to study BTAF1 function
Our results show that the surface of TBP involved in BTAF1
binding overlaps with surfaces contacted by other factors.
However, we were able to select several evolutionarily con-
served residues differently affected for the binding of BTAF1,
TFIIA and NC2 (Figure 5). Such mutations can be used
to dissect separate functions of distinct TBP complexes
both in vitro and in vivo. Most importantly, both TFIIA and
NC2 were suggested to antagonize BTAF1 or Mot1p binding
to TBP (14,20). By using specific TBP mutants the role of
BTAF1 in TBP function could be studied without the inter-
ference from other factors.
Taken together, we present a comprehensive study of the
TBP surfaces involved in BTAF1 transcription factor binding.
This allowed the investigation of various aspects of BTAF1
function, such as stabilization of TBP binding to DNA and
dissociation of TBP–DNA complexes. We also suggest a cent-
ral role of helix 2 interacting factors, BTAF1, TFIIA and NC2,
in facilitation of TBP binding to DNA.
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